Table 1. Clinical parameters of the DLBCL patients study group (n = 280).
Parameter | Frequency |
---|---|
Age | |
<70 years | 107 (38.2%) |
M 70 years | 173 (61.8%) |
Sex | |
M | 148 (52.9%) |
F | 132 (47.1%) |
ECOG score | |
0+1 | 169 (60.4%) |
2-3 | 111 (39.6%) |
B-symptoms | |
No | 113 (40.4%) |
Yes | 167 (59.6%) |
IPI score | |
0–2 | 107 (38.2%) |
3–5 | 173 (61.8%) |
Stage | |
I–II | 42 (15.0%) |
III–IV | 238 (85.0%) |
Extranodal involvement | |
No | 145 (51.8%) |
Yes | 135 (48.2%) |
Leukemization | |
No | 199 (71.1%) |
Yes | 81 (28.9%) |
LDH level | |
Normal | 153 (54.6%) |
Elevated | 127 (45.4%) |
Note:
ECOG, Eastern Cooperative Oncology Group; IPI, International Prognostic Index; LDH, Lactate dehydrogenase.